A Study to Evaluate Administration of SBT101 Gene Therapy in Adult Patients With Adrenomyeloneuropathy (AMN)

Clinical trial NCT05394064 · TERMINATED

Trial details

NCT number: NCT05394064
Sponsor: SwanBio Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

AMN AMN Gene Mutation X-ALD

Start date: 2022-11-17
Primary completion: 2025-06-30
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.